Advanced search×

Platelet-Activating Factor Blockade Inhibits the T-Helper Type 17 Cell Pathway and Suppresses Psoriasis-Like Skin Disease in K5.hTGF-@b1 Transgenic Mice

Tej Pratap Singh, Barbara Huettner, Harald Koefeler, Gerlinde Mayer, Isabella Bambach, Katrin Wallbrecht, Michael P Schön, and Peter Wolf

Am J Pathol 178(2):10 (2011) PMID 21281802 PMCID PMC3070583

Platelet-activating factor (PAF), a potent biolipid mediator, is involved in a variety of cellular transduction pathways and plays a prominent role in inducing inflammation in different organs. We used K5.hTGF-@b1 transgenic mice, which exhibit an inflammatory skin disorder and molecular and cytokine abnormalities with strong similarities to human psoriasis, to study the pathogenic role of PAF. We found that injecting PAF into the skin of transgenic mice led to inflammation and accelerated manifestation of the psoriatic phenotype by a local effect. In contrast, injecting mice with PAF receptor antagonist PCA-4248 lowered the PAF level (most likely by depressing an autocrine loop) and neutrophil, CD68^+ cell (monocyte/macrophage), and CD3^+ T-cell accumulation in the skin and blocked progression of the psoriasis-like phenotype. This effect of PAF blockade was specific and similar to that of psoralen-UV-A and was paralleled by a decrease in abnormally elevated mRNA and/or protein levels of T-helper type 17 cell-related cytokines IL-17A, IL-17F, IL-23, IL-12A, and IL-6 and its transcription factor signal transducer and activator of transcription 3. In contrast, PCA-4248 treatment up-regulated mRNA levels of cyclooxygenase-2 and IL-10 in dorsal skin and release of IL-10 in serum and skin. Interfering with PAF may offer the opportunity to develop novel therapeutic strategies for inflammatory psoriasis and associated comorbidities, including metabolic syndrome and atherosclerosis, in which the IL-17 axis may be involved.

Copyright © 2011 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.ajpath.2010.10.008
Version: za2963e q8za3 q8zb4 q8zcc q8zd1 q8ze6 q8zf8 q8zg0
View PDF

Similar articles you may find interesting…

  1. Purification and characterization of a native zinc-binding high molecular weight multiprotein complex from human seminal plasma.
    Vikash Kumar VK Yadav, Vijay V Kumar, ... Savita S Yadav

    J Sep Sci 34(9):1076-83 (2011) PMID 21404442

    We report the identification and characterization of a native high molecular weight zinc-binding multiprotein complex from HuSP by utilizing 2-DE followed by MS. Twenty-six proteins representing isoforms and/or fragments of 11 different proteins were found to be assembled in this complex. Prostate-s...
  2. 8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving...
    Tej Pratap TP Singh, Michael P MP Schön, ... Peter P Wolf

    Audio, Transactions of the IRE Profess... 184(12):7257-67 (2010) PMID 20488788

    We used K5.hTGF-beta1 transgenic mice exhibiting a skin phenotype and cytokine abnormalities with strong similarities to human psoriasis. We observed that impaired function of CD4+CD25+ regulatory T cells (Tregs) and increased cytokine levels of the IL-23/Th17 pathway were responsible for the psoria...
  3. hCDC4 gene mutations in endometrial cancer.
    Charles H CH Spruck, Heimo H Strohmaier, ... Steven I SI Reed

    Cancer Res 62(16):4535-9 (2002) PMID 12183400

    We show that the F-box protein hCdc4 that targets cyclin E to the SCF (Skp1-Cull-F-box) protein ubiquitin ligase is mutated in at least 16% of human endometrial tumors. Mutations were found either in the substrate-binding domain of the protein or at the amino terminus, suggesting a critical role for...